Effect of acute lipopolysaccharide-induced inflammation in intracerebroventricular-streptozotocin injected rats

Neuropharmacology
Andrew S MurtishawJefferson W Kinney

Abstract

Lipopolysaccharide (LPS) is often used to investigate the exacerbatory effects of an immune-related challenge in transgenic models of various neurodegenerative diseases. However, the effects of this inflammatory challenge in an insulin resistant brain state, as seen in diabetes mellitus, a major risk factor for both vascular dementia (VaD) and Alzheimer's disease (AD), is not as well characterized. We investigated the effects of an LPS-induced inflammatory challenge on behavioral and biological parameters following intracerebroventricular (ICV) injection of streptozotocin (STZ) in male Sprague-Dawley rats. Subjects received a one-time bilateral ICV infusion of STZ (25 mg/mL, 8 μL per ventricle) or ACSF. One week following ICV infusions, LPS (1 mg/mL, i.p.) or saline was administered to activate the immune system. Behavioral testing began on the 22nd day following STZ-ICV infusion, utilizing the open field and Morris water maze (MWM) tasks. Proteins related to immune function, learning and memory, synaptic plasticity, and key histopathological markers observed in VaD and AD were evaluated. The addition of an LPS-induced immune challenge partially attenuated spatial learning and memory deficits in the MWM in STZ-ICV injected anim...Continue Reading

References

Oct 1, 1986·Physiology & Behavior·J P Kroon, A L Riley
Jan 1, 1995·Neurobiology of Learning and Memory·I Izquierdo, J H Medina
Nov 5, 1997·Annals of the New York Academy of Sciences·C L LeibsonP J Palumbo
Aug 28, 1998·Journal of Neural Transmission·L FrölichP Riederer
Sep 2, 1998·Proceedings of the National Academy of Sciences of the United States of America·J K HarrisonL Feng
Aug 28, 1999·The Journal of Biological Chemistry·D M WalshD B Teplow
Dec 22, 1999·Neurology·A OttM M Breteler
Oct 18, 2000·Proceedings of the National Academy of Sciences of the United States of America·X FangG B Mills
May 30, 2001·Molecular and Cellular Endocrinology·W Q Zhao, D L Alkon
Mar 23, 2002·Journal of Neurochemistry·F GardoniM Di Luca
Oct 26, 2002·Science·Dennis J Selkoe
May 10, 2003·Neurobiology of Learning and Memory·Jefferson W KinneyJacqueline N Crawley
Apr 20, 2004·European Journal of Pharmacology·Siegfried Hoyer
May 19, 2004·Archives of Neurology·Zoe ArvanitakisDavid A Bennett
Mar 17, 2006·Nature·Sylvain LesnéKaren H Ashe
Dec 21, 2006·Nature Reviews. Neuroscience·Michelle L BlockJau-Shyong Hong
Sep 6, 2007·Neurology·A R deIpolyiM L Gorno-Tempini
Apr 25, 2009·Acta Neuropathologica·Thomas Arendt
Jun 18, 2009·Neurobiology of Learning and Memory·Jefferson W KinneyTamas Bartfai
Oct 21, 2009·Neuron·V Wee Yong, Serge Rivest
Aug 25, 2010·Journal of Neurochemistry·Nadim S JiwaAtticus H Hainsworth
Nov 13, 2010·Annals of the New York Academy of Sciences·Bengt F Belgardt, Jens C Brüning
May 3, 2011·Journal of Neural Transmission·Melita Salkovic-PetrisicPeter Riederer
May 10, 2012·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·B C BorgesL L K Elias
Aug 18, 2012·The International Journal of Neuroscience·Jonathan J SabbaghJefferson W Kinney
Sep 15, 2012·Physiology & Behavior·Jonathan J SabbaghJefferson W Kinney
Sep 27, 2012·Neurobiology of Learning and Memory·Chelcie F HeaneyJefferson W Kinney
Oct 2, 2012·Journal of Neuroimmunology·Shivika RaiRakesh Shukla

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.